mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.024 |
0.7 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.7 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.023 |
0.7 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |